Identification of the Gene Responsible for Best Macular Dystrophy
Konstantin Petrukhin, Markus J. Koisti, Benjamin Bakall, Wen Li, Guochun Xie, Towa Marknell, Ola Sandgren, Kristina Forsman, Gösta Holmgren, Sten Andreasson, Mihailo Vujic, Arthur A. B. Bergen, Valarie McGarty-Dugan, David Figueroa, Christopher P. Austin, Michael L. Metzker, C. Thomas Caskey, Claes Wadelius
Best macular dystrophy (BMD), also known as vitelliform macular dystrophy (VMD2; OMIM 153700), is an autosomal dominant form of macular degeneration characterized by an abnormal accumulation of lipofuscin within and beneath the retinal pigment epithelium cells. In pursuit of the disease gene, we limited the minimum genetic region by recombination breakpoint analysis and mapped to this region a novel retina-specific gene (VMD2). Genetic mapping data, identification of 5 independent disease-specific mutations and expression studies provide evidence that mutations within the candidate gene are a cause of BMD. The 3‘ UTR of the candidate gene contains a region of antisense complementarity to the 3‘ UTR of the ferritin heavy-chain gene (FTH1), indicating the possibility of antisense interaction between VMD2 and FTH1 transcripts.
Dryja TP. The Best Excitement in Age-related Macular Degeneration. Arch Ophthalmol. 1999;117(1):108–109. doi:10.1001/archopht.117.1.108
Monkeypox Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.